YS Biopharma Co. Ltd. (NASDAQ:YS) concluded the trading at $0.90 on Friday, September 15 with a fall of -0.41% from its closing price on previous day.
Taking a look at stock we notice that its last check on previous day was $0.90 and 5Y monthly beta was reading -0.34 with its price kept floating in the range of $0.86 and $1.08 on the day. Company’s P/E ratio for the trailing 12 months is 1.31. Considering stock’s 52-week price range provides that YS hit a high price of $18.44 and saw its price falling to a low level of $0.75 during that period. Over a period of past 1-month, stock came subtracting -18.18% in its value.
With its current market valuation of $92.85 million. Analysts are in estimates of -$0.08 per share for company’s earnings in the current quarter and are expecting its annual EPS growth moving up to $0 for 2024 with estimates of that growing to -$0.33 in next year.
Analysts watching the company’s growth closely have provided estimates for its revenue growth with an average revenue estimate of $23.02 million. They suggested that in the process company could generate revenue of as low as $23.02 million which could climb up to $23.02 million to hit a high.
In last 7 days, analysts came adjusting their opinions about stock’s EPS with no upward and no downward revisions, an indication which could give clearer idea about the company’s short term price movement.
Digging deeper we become aware of the PEG ratio of the YS stock which is currently positioned at 0. It further provides that stock’s current price level is -12.97% away from its 20-day simple moving average and is -25.81% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 35.72 while volatility remained at 11.22% over the past week which changes to 11.58% when measuring it over the past month. Beta is valued at -0.36, while measure of average true range or ATR is currently at 0.12.
Having a second look at YS Biopharma Co. Ltd. (NASDAQ:YS) provides that stock’s average daily trading volume for 3 months was 954.27K, while it jumped to 0.38 million when we calculate an average volume for past 10 days. Number of outstanding shares of the stock stood at 93.06 million.
The figures also indicate that as of Aug 30, 2023, number of stock’s short shares was 0.71 million which implies a short ratio of 0.33. This shows up a 0.76% of Short Interest in company’s outstanding shares on the day. In August the standing of shares short improved as it was 0.31 million in the previous month. Subtraction of -91.02% by stock’s current price to its year-to-date value in last trading session is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.